The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics used to treat psoriasis, said Strober. The momentum can be traced to an ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Black Health Matters (BHM), the nation's leading health equity platform dedicated to improving the health outcomes of Black ...